About My Health Careers Internship MedBlogs Contact us

Second Line Drugs for HIV and TB Made Available If India Joins UNITAID

by VR Sreeraman on September 25, 2007 at 4:09 PM
Font : A-A+

Second Line Drugs for HIV and TB Made Available If India Joins UNITAID

In a significant development addressing the medicinal needs of people living with HIV and TB, UNITAID, a frontal organisation of the United Nations and the World Health Organisation (WHO), has asked India to be signatory.

Talking to ANI from Geneva, Dr. Sundar, a physician, who is a part of UNITAID in India, said, "If India aggress to join this initiative like that of over 30 other countries, this would save millions of people living with HIV and TB, who need Second Line Drugs (SLD) for their survival."


Further, he said that the National AIDS Control Organisation (NACO), a nodal agency in India, should take up this initiative.

According to Dr. Sundar, Geneva-based UNITAID, has already appealed to Indian Prime Minister Dr. Manmohan Singh in this regard and is waiting for a response.

With the rise in cases of deadly and highly contagious Multi-Drug Resistant Tuberculosis (MDR-TB), Extensively Drug Resistant Tuberculosis (XDR-TB) and HIV, second line medication is a s vital as the First Line Drugs.

SLD are the only hope for sustaining life, yet these drugs are much more expensive and as the market are less developed, often impossible to find where they are needed.

Although, at present, India provides first line treatment for HIV and TB free of cost, access to the second line of lifesaving drugs is denied to all those without means to buy these essential but expensive medicines.

UNITAID is an international drug purchase facility to accelerate access to high quality drugs and diagnostics for HIV/AIDS, malaria and TB in developing countries.

Launched in 2006, UNITAID is hosted and administered by WHO with an operational budget of over 300 millions dollars collected through air ticket levy.

Brazil, Chile, France, Norway, United Kingdom, Spain, South Korea, and many African and Asian Countries are members. These countries are raising funds through air ticket levy and wants India to join and raise funds through a small air ticket levy to save millions.

WHO, UNICEF, Global Fund, Clinton Foundation and Global Drug Facility are operating partners to UNITAID.

India has over three million people living with HIV and the second line drugs are crucial to save millions of life. It is crucial that India joins the UNITAID.

For Celina D'Costa of Indian Network for People Living with HIV/AIDS, in Delhi, one of the oldest living with HIV, the Indian initiative was crucial and saves millions of lives who need second line drugs.

For Stanzin Dawa of Alliance in India, an NGO supporting community action on AIDS in India, this initiative helps millions to afford second line drugs and a small air ticket levy would save millions.

According to sources, more than 20 countries have already levied an air ticket tax including France, South Korea, Chile and some other countries.

In the year since it was established, the international drug purchase facility UNITAID has managed to reduce the price of HIV treatments for children by almost 40 percent, and those for second-line antiretroviral (ARV) drugs by between 25 percent and 50 percent respectively.

In collaboration with the Clinton Foundation, UNITAID has also delivered more than 33 000 paediatric treatments against HIV/AIDS and is on course to meet the needs of 100 000 children by the end of 2007.

Source: ANI

News A-Z
News Category
What's New on Medindia
Goji Berries May Protect Against Age-Related Vision Loss
Tapping — A Proven Self-Applied Stress Intervention
Black Pepper as Preventive Measure Against Omicron
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Oral Health And AIDS Drug Toxicity Tuberculosis AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs 

Recommended Reading
AIDS / HIV - Treatment
Encyclopedia section of medindia explains in brief about the treatment for AIDS/HIV...
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to ......
New "second-line" AIDS Drug Shows Promise in Trials
An experimental drug that researchers hope will cast a lifeline to HIV patients who have exhausted ....
India To Establish Lab Network To Increase Detection of MDR-TB Cases
The Indian government plans to establish a laboratory network to increase the detection of ......
"AIDS is an epidemic disease, a potentially preventable, deadly infection for which there is no cure...
AIDS/HIV - Clinical Features
Encyclopedia section of medindia gives general info about HIV Clinical Features...
AIDS/HIV - Epidemiology
AIDS or HIV is an epidemic disease, a potentially deadly infection that can be prevented with preca...
AIDS/HIV - Health Education
Encyclopedia section of medindia gives general info about AIDS information and health education....
AIDS/HIV - Prevention And Transmission
Encyclopedia section of medindia explains in brief about the prevention for AIDS/HIV...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Oral Health And AIDS
AIDS has taken on massive proportions in modern times. It is estimated that over 15 million people a...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)